Pacific Edge Limited Logo

Pacific Edge Limited

PEB.AX

(1.0)
Stock Price

0,13 AUD

-42.01% ROA

-47.11% ROE

-3.67x PER

Market Cap.

107.496.379,33 AUD

7.46% DER

0% Yield

-117.07% NPM

Pacific Edge Limited Stock Analysis

Pacific Edge Limited Fundamental Analysis

Fundamental analysis in stock investing is like studying the foundation of a house before buying it. It involves looking at a company's financial health, like its earnings, assets, and debts, to determine if it's a good investment based on its fundamental strength and potential for growth.

Pacific Edge Limited Fundamental Stock Analysis
# Analysis Rating
1 DER

The stock has a minimal amount of debt (1%) relative to its ownership, showcasing a strong financial position and lower risk for investors.

2 PBV

The stock's PBV ratio (1.05x) indicates a justifiable valuation, presenting a compelling choice for investors seeking reasonable returns.

3 Graham Number

The Graham number of this company suggests that its stock price may be undervalued, indicating a potentially attractive investment opportunity.

4 ROE

Negative ROE (-26.31%) indicates poor financial performance, raising concerns about profitability and efficiency in utilizing shareholders' equity.

5 ROA

The stock's ROA (-28.06%) indicates that it's not effectively utilizing its assets to generate profits, making it a less favorable option to invest and earn consistent returns.

6 Revenue Growth

Company's revenue has stayed stagnant, showing no signs of improvement and making it a less favorable choice.

7 Net Profit Growth

Over the past five years, this company's net profit has failed to exhibit any growth, indicating a stagnant financial performance and making it a less favorable choice for potential investors.

8 Assets Growth

Company has experienced no growth in revenue over the past three years, suggesting limited profitability and making it a less desirable investment opportunity.

9 Dividend Growth

The company's dividend growth has remained unchanged for three years, signaling a lack of positive momentum and making it a less favorable investment choice.

10 Dividend

No dividends from the company in the past three years raises doubts about its profitability for shareholders.

11 Buffet Intrinsic Value

Warren Buffett's formula suggests that the company's stock is overpriced (0), presenting a possible disadvantage for investors as its market price surpasses its estimated intrinsic value.

Pacific Edge Limited Technical Analysis

Technical analysis in stock investing is like reading the patterns on a weather map to predict future weather conditions. It involves studying past stock price movements and trading volumes to make predictions about where a stock's price might go next, without necessarily looking at the company's financial health.

Pacific Edge Limited Technical Stock Analysis
# Analysis Recommendation
1 Awesome Oscillator Hold
2 MACD Sell
3 RSI Hold
4 Stoch RSI Sell

Pacific Edge Limited Price Chart

Financial Statements

Financial statements are like report cards for companies. They show how much money a company makes (income statement), what it owns and owes (balance sheet), and where it spends its money (cash flow statement), helping stock investors understand if a company is healthy and worth investing in.

Income Statements

An income statement for a company is like a scoreboard for its profits and losses. It shows how much money the company made (revenue) and how much it spent to make that money (expenses), helping stock investors see if a company is making a profit or not.

Revenue in stock investing is the total amount of money a company earns from its sales, and it's a key factor that investors consider to assess a company's financial performance and growth potential.

Pacific Edge Limited Revenue
Year Revenue Growth
2005 50.000
2006 0 0%
2007 0 0%
2008 82.000 100%
2009 220.000 62.73%
2010 0 0%
2011 500 100%
2012 198.000 99.75%
2013 182.000 -8.79%
2014 523.000 65.2%
2015 1.900.000 72.47%
2016 4.975.532 61.81%
2017 8.061.994 38.28%
2018 3.400.000 -137.12%
2019 3.817.000 10.92%
2020 4.370.000 12.65%
2021 2.152.000 -103.07%
2022 11.445.000 81.2%
2023 19.616.000 41.65%
2024 22.550.000 13.01%

Research and Development Expenses are the costs a company incurs to create and improve its products or services, which can be important for investors to evaluate a company's innovation and potential for future growth.

Pacific Edge Limited Research and Development Expenses
Year Research and Development Expenses Growth
2005 1.586.995
2006 1.903.240 16.62%
2007 1.751.410 -8.67%
2008 536.807 -226.26%
2009 0 0%
2010 1.330.796 100%
2011 20.130 -6511.01%
2012 0 0%
2013 2.142.915 100%
2014 99.373 -2056.44%
2015 4.707.260 97.89%
2016 4.442.459 -5.96%
2017 3.362.953 -32.1%
2018 4.914.000 31.56%
2019 1.798.000 -173.3%
2020 3.916.000 54.09%
2021 4.584.000 14.57%
2022 5.135.000 10.73%
2023 8.484.000 39.47%
2024 25.558.000 66.8%

General and Administrative Expenses are the costs a company incurs to run its day-to-day operations, such as office rent, salaries, and utilities, which investors consider to understand a company's overall efficiency and management effectiveness.

Pacific Edge Limited General and Administrative Expenses
Year General and Administrative Expenses Growth
2005 218.926
2006 122.577 -78.6%
2007 116.805 -4.94%
2008 117.000 0.17%
2009 124.000 5.65%
2010 124.000 0%
2011 143.000 13.29%
2012 157.000 8.92%
2013 377.000 58.36%
2014 665.000 43.31%
2015 750.000 11.33%
2016 10.519.698 92.87%
2017 15.693.299 32.97%
2018 5.787.000 -171.18%
2019 8.026.000 27.9%
2020 5.810.000 -38.14%
2021 4.790.000 -21.29%
2022 4.047.000 -18.36%
2023 5.986.000 32.39%
2024 7.066.000 15.28%

EBITDA stands for Earnings Before Interest, Taxes, Depreciation, and Amortization. It is a measure that helps stock investors analyze a company's profitability by looking at its earnings without considering certain expenses. This helps to get a clearer picture of the company's financial performance and its ability to generate cash flow.

Pacific Edge Limited EBITDA
Year EBITDA Growth
2005 -2.150.000
2006 -1.695.944 -26.77%
2007 -1.725.746 1.73%
2008 -1.806.000 4.44%
2009 -2.863.000 36.92%
2010 -3.358.000 14.74%
2011 -3.249.000 -3.35%
2012 -4.350.000 25.31%
2013 -6.719.000 35.26%
2014 -9.882.000 32.01%
2015 -12.502.000 20.96%
2016 -17.387.853 28.1%
2017 -21.911.040 20.64%
2018 -21.246.000 -3.13%
2019 -19.025.000 -11.67%
2020 -19.279.000 1.32%
2021 -22.097.000 12.75%
2022 -21.800.000 -1.36%
2023 -32.797.000 33.53%
2024 -30.998.000 -5.8%

Gross profit is the money a company makes from selling its products or services after subtracting the cost of producing or providing them, and it is an important measure for investors to understand a company's profitability.

Pacific Edge Limited Gross Profit
Year Gross Profit Growth
2005 50.000
2006 0 0%
2007 0 0%
2008 -51.619 100%
2009 220.000 123.46%
2010 0 0%
2011 500 100%
2012 108.835 99.54%
2013 40.087 -171.5%
2014 -2.736.274 101.47%
2015 -2.703.372 -1.22%
2016 -514.366 -425.57%
2017 -1.953.006 73.66%
2018 -5.603.000 65.14%
2019 -777.000 -621.11%
2020 -811.000 4.19%
2021 -3.314.000 75.53%
2022 4.947.000 166.99%
2023 10.267.000 51.82%
2024 11.330.000 9.38%

Net income in stock investing is like the money a company actually gets to keep as profit after paying all its bills, and it's an important measure to understand how well a company is doing financially.

Pacific Edge Limited Net Profit
Year Net Profit Growth
2005 -2.848.000
2006 -2.516.838 -13.16%
2007 -1.880.836 -33.81%
2008 -1.918.000 1.94%
2009 -2.474.000 22.47%
2010 -2.528.000 2.14%
2011 -3.123.000 19.05%
2012 -4.078.000 23.42%
2013 -6.917.000 41.04%
2014 -9.951.000 30.49%
2015 -10.729.000 7.25%
2016 -15.676.391 31.56%
2017 -20.980.302 25.28%
2018 -19.644.000 -6.8%
2019 -17.918.000 -9.63%
2020 -18.886.000 5.13%
2021 -14.223.000 -32.78%
2022 -19.788.000 28.12%
2023 -26.965.000 26.62%
2024 -28.566.000 5.6%

EPS, or earnings per share, is a measure that shows how much profit a company has earned for each outstanding share of its stock, and it is important for stock investors as it helps understand the profitability of a company and compare it with other companies in the market.

Pacific Edge Limited Earning per Share (EPS)
Year Earning per Share (EPS) Growth
2005 0
2006 0 0%
2007 0 0%
2008 0 0%
2009 0 0%
2010 0 0%
2011 0 0%
2012 0 0%
2013 0 0%
2014 0 0%
2015 0 0%
2016 0 0%
2017 0 0%
2018 0 0%
2019 0 0%
2020 0 0%
2021 0 0%
2022 0 0%
2023 0 0%
2024 0 0%

Cashflow Statements

Cashflow statements show the movement of money in and out of a company, helping stock investors understand how much money a company makes and spends. By examining cashflow statements, investors can assess if a company is generating enough cash to pay its bills, invest in growth, and provide returns to stockholders.

Free cash flow is the leftover cash that a company generates after covering its operating expenses and capital expenditures, which is important for stock investors as it shows how much money a company has available to invest in growth, pay dividends, or reduce debt.

Pacific Edge Limited Free Cashflow
Year Free Cashflow Growth
2005 -39.000
2006 -247.726 84.26%
2007 0 0%
2008 -37.000 100%
2009 -129.000 71.32%
2010 -121.000 -6.61%
2011 -308.000 60.71%
2012 -31.000 -893.55%
2013 -7.719.436 99.6%
2014 -10.020.612 22.96%
2015 -12.965.751 22.71%
2016 -17.276.931 24.95%
2017 -18.315.983 5.67%
2018 -18.435.000 0.65%
2019 -17.663.000 -4.37%
2020 -15.568.000 -13.46%
2021 -13.948.000 -11.61%
2022 -18.678.000 25.32%
2023 -28.484.000 34.43%
2024 -5.551.500 -413.09%

Operating cash flow represents the cash generated or consumed by a company's day-to-day operations, excluding external investing or financing activities, and is crucial for stock investors as it shows how much cash a company is generating from its core business operations.

Pacific Edge Limited Operating Cashflow
Year Operating Cashflow Growth
2005 0
2006 0 0%
2007 0 0%
2008 0 0%
2009 0 0%
2010 0 0%
2011 0 0%
2012 0 0%
2013 -6.710.436 100%
2014 -9.523.612 29.54%
2015 -12.538.751 24.05%
2016 -16.952.360 26.04%
2017 -17.837.000 4.96%
2018 -18.100.000 1.45%
2019 -17.507.000 -3.39%
2020 -15.385.000 -13.79%
2021 -13.570.000 -13.38%
2022 -17.552.000 22.69%
2023 -25.575.000 31.37%
2024 -5.379.000 -375.46%

Capex, short for capital expenditures, refers to the money a company spends on acquiring or upgrading tangible assets like buildings, equipment, or technology, which is important for stock investors as it indicates how much a company is investing in its infrastructure to support future growth and profitability.

Pacific Edge Limited Capital Expenditure
Year Capital Expenditure Growth
2005 39.000
2006 247.726 84.26%
2007 0 0%
2008 37.000 100%
2009 129.000 71.32%
2010 121.000 -6.61%
2011 308.000 60.71%
2012 31.000 -893.55%
2013 1.009.000 96.93%
2014 497.000 -103.02%
2015 427.000 -16.39%
2016 324.571 -31.56%
2017 478.983 32.24%
2018 335.000 -42.98%
2019 156.000 -114.74%
2020 183.000 14.75%
2021 378.000 51.59%
2022 1.126.000 66.43%
2023 2.909.000 61.29%
2024 172.500 -1586.38%

Balance Sheet

Balance sheets provide a snapshot of a company's financial health and its assets (such as cash, inventory, and property) and liabilities (like debts and obligations) at a specific point in time. For stock investors, balance sheets help assess the company's overall worth and evaluate its ability to meet financial obligations and support future growth.

Equity refers to the ownership interest or stake that shareholders have in a company, representing their claim on its assets and earnings after all debts and liabilities are paid.

Pacific Edge Limited Equity
Year Equity Growth
2005 1.117.393
2006 974.166 -14.7%
2007 336.808 -189.23%
2008 2.425.908 86.12%
2009 257.171 -843.31%
2010 1.128.903 77.22%
2011 2.690.644 58.04%
2012 17.677.922 84.78%
2013 11.145.203 -58.61%
2014 21.778.008 48.82%
2015 10.702.533 -103.48%
2016 29.807.470 64.09%
2017 20.828.891 -43.11%
2018 16.640.000 -25.17%
2019 13.910.000 -19.63%
2020 14.504.000 4.1%
2021 25.109.000 42.24%
2022 116.596.019 78.46%
2023 88.412.562 -31.88%
2024 59.546.495 -48.48%

Assets represent the valuable resources that a company owns, such as cash, inventory, property, and equipment, and understanding a company's assets helps investors assess its value and potential for generating future profits.

Pacific Edge Limited Assets
Year Assets Growth
2005 1.383.101
2006 1.294.870 -6.81%
2007 562.963 -130.01%
2008 3.178.430 82.29%
2009 896.613 -254.49%
2010 1.801.020 50.22%
2011 3.294.990 45.34%
2012 18.646.756 82.33%
2013 12.222.787 -52.56%
2014 22.731.183 46.23%
2015 12.633.316 -79.93%
2016 32.330.804 60.92%
2017 23.563.202 -37.21%
2018 19.665.000 -19.82%
2019 16.566.000 -18.71%
2020 19.328.000 14.29%
2021 31.184.000 38.02%
2022 124.025.820 74.86%
2023 97.118.897 -27.71%
2024 71.348.522 -36.12%

Liabilities refer to the financial obligations or debts that a company owes to creditors or external parties, and understanding a company's liabilities is important for investors as it helps assess the company's financial risk and ability to meet its obligations.

Pacific Edge Limited Liabilities
Year Liabilities Growth
2005 265.708
2006 320.704 17.15%
2007 226.155 -41.81%
2008 752.522 69.95%
2009 639.442 -17.68%
2010 672.117 4.86%
2011 604.346 -11.21%
2012 968.834 37.62%
2013 1.077.584 10.09%
2014 953.175 -13.05%
2015 1.930.783 50.63%
2016 2.523.334 23.48%
2017 2.734.311 7.72%
2018 3.025.000 9.61%
2019 2.656.000 -13.89%
2020 4.824.000 44.94%
2021 6.075.000 20.59%
2022 7.429.800 18.23%
2023 8.706.334 14.66%
2024 11.802.027 26.23%

Pacific Edge Limited Financial Ratio (TTM)

Valuation Metrics

Revenue per Share
0.03
Net Income per Share
-0.04
Price to Earning Ratio
-3.67x
Price To Sales Ratio
4.26x
POCF Ratio
-4.21
PFCF Ratio
-4.04
Price to Book Ratio
1.82
EV to Sales
2.25
EV Over EBITDA
-1.73
EV to Operating CashFlow
-2.21
EV to FreeCashFlow
-2.14
Earnings Yield
-0.27
FreeCashFlow Yield
-0.25
Market Cap
0,11 Bil.
Enterprise Value
0,06 Bil.
Graham Number
0.24
Graham NetNet
0.08

Income Statement Metrics

Net Income per Share
-0.04
Income Quality
0.87
ROE
-0.47
Return On Assets
-0.41
Return On Capital Employed
-0.54
Net Income per EBT
1
EBT Per Ebit
0.88
Ebit per Revenue
-1.33
Effective Tax Rate
0.03

Margins

Sales, General, & Administrative to Revenue
0.37
Research & Developement to Revenue
0.97
Stock Based Compensation to Revenue
0.05
Gross Profit Margin
0.53
Operating Profit Margin
-1.33
Pretax Profit Margin
-1.17
Net Profit Margin
-1.17

Dividends

Dividend Yield
0
Dividend Yield %
0
Payout Ratio
0
Dividend Per Share
0

Operating Metrics

Operating Cashflow per Share
-0.03
Free CashFlow per Share
-0.03
Capex to Operating CashFlow
-0.03
Capex to Revenue
0.03
Capex to Depreciation
0.41
Return on Invested Capital
-0.51
Return on Tangible Assets
-0.42
Days Sales Outstanding
74.1
Days Payables Outstanding
72.9
Days of Inventory on Hand
57.16
Receivables Turnover
4.93
Payables Turnover
5.01
Inventory Turnover
6.39
Capex per Share
0

Balance Sheet

Cash per Share
0,09
Book Value per Share
0,07
Tangible Book Value per Share
0.07
Shareholders Equity per Share
0.07
Interest Debt per Share
0.01
Debt to Equity
0.07
Debt to Assets
0.06
Net Debt to EBITDA
1.54
Current Ratio
6.96
Tangible Asset Value
0,06 Bil.
Net Current Asset Value
0,05 Bil.
Invested Capital
62281696
Working Capital
0,05 Bil.
Intangibles to Total Assets
0.01
Average Receivables
0,00 Bil.
Average Payables
0,00 Bil.
Average Inventory
1764091.5
Debt to Market Cap
0.04

Dividends

Dividends in stock investing are like rewards that companies give to their shareholders. They are a portion of the company's profits distributed to investors, typically in the form of cash payments, as a way for them to share in the company's success.

Pacific Edge Limited Dividends
Year Dividends Growth

Pacific Edge Limited Profile

About Pacific Edge Limited

Pacific Edge Limited, a cancer diagnostic company, researches, develops, and commercializes diagnostic and prognostic tools for the early detection and management of cancers in New Zealand, the United States, Australia, and Singapore. It operates in two segments, Commercial and Research. The company offers Cxbladder, a genomic urine tests for the detection and management of bladder cancer. It is also developing Cxbladder Resolve, a product that identifies those patients who are likely to have aggressive or more advanced bladder cancer; Cxbladder Triage, a product that identifies patients with haematuria who have a low probability of bladder cancer; Cxbladder Detect that enables the non-invasive detection of bladder and other urinary tract cancers; and Cxbladder Monitor, which allows urologists to monitor bladder cancer patients for recurrence of the disease. In addition, the company is developing Cxcolorectal, a prognostic gene signature for patients diagnosed with stage II or stage III colorectal cancers; and products for bladder, gastric, colorectal, endometrial cancers, and melanoma. Pacific Edge Limited was incorporated in 2001 and is headquartered in Dunedin, New Zealand.

CEO
Dr. Peter Meintjes
Employee
114
Address
Centre for Innovation
Dunedin, 9016

Pacific Edge Limited Executives & BODs

Pacific Edge Limited Executives & BODs
# Name Age
1 Dr. Peter Meintjes
Chief Executive Officer
70
2 Mr. David Levison
Executive Chairman & President of Pacific Edge Diagnostics USA
70
3 Prof. Parry Guilford Ph.D.
Chief Scientific Officer & Member of Scientific Advisory Board
70
4 Glen Costin
President of Asia Pacific
70
5 Dr. Tamer Aboushwareb
Chief Medical Officer
70
6 Mr. Grant Gibson
Chief Financial Officer
70
7 Dr. Justin Harvey
Chief Technology Officer
70
8 Mr. Andrew McIntosh
Chief Digital Officer
70
9 Mr. Darrell Morgan
Chief Operating Officer
70

Pacific Edge Limited Competitors